Spending on cessation therapies decreasing but 1 in 5 still smoke

Publisher： John Wiley & Sons Inc

E-ISSN： 1931-2253|26|17|10-10

ISSN： 0959-6682

Source： PRESCRIBER, Vol.26, Iss.17, 2015-09, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on smoking cessation therapies

By Glynn Deirdre  

Advances in Therapy, Vol. 26, Iss. 4, 2009-04 ,pp. : 369-382

Springer Publishing Company

Access to resources Recommend Favorite

Caveolin-1 aggravates cigarette smoke extract-induced MUC5AC secretion in human airway epithelial cells

By          

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1435-1442

Spandidos Publications

Access to resources Recommend Favorite

The role of second‐hand smoke exposure on smoking cessation in non–tobacco‐related cancers

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2655-2663

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intensive Hypnotherapy for Smoking Cessation: A Prospective Study 1

By ELKINS GARY   MARCUS JOEL   BATES JEFF   Hasan Rajab M.   COOK TERESA  

International Journal of Clinical and Experimental Hypnosis, Vol. 54, Iss. 3, 2006-09 ,pp. : 303-315

Routledge Ltd

Access to resources Recommend Favorite

Lack of Association of OPRM1 Genotype and Smoking Cessation

By Munafò Marcus R.  

Nicotine & Tobacco Research, Vol. 15, Iss. 3, 2013-03 ,pp. : 739-744

Oxford University Press

Access to resources Recommend Favorite